Association Between Prophylactic Anti-Seizure Medication and Early Post-Traumatic Seizures: An International Observational Multicenter Study

  • Jian Ji
  • , Juan D. Roa G
  • , Shu Ling Chong
  • , Quan Wang
  • , Chin Seng Gan
  • , Jane P.W. Ng
  • , Thelma Elvira Teran Miranda
  • , Freddy Israel Pantoja Chamorro
  • , Lawrence Chi Ngong Chan
  • , Qalab Abbas
  • , Jacqueline S.M. Ong
  • , Ivan J. Ardila
  • , Yasser M. Kazzaz
  • , Jesús A. Domínguez-Rojas
  • , Hiroshi Kurosawa
  • , Susana Beatriz Reyes Domínguez
  • , Natalia Elizabeth Gómez Arriola
  • , Natalia Zita Watzlawik
  • , Adriana Yock-Corrales
  • , Rubén Eduardo Lasso Palomino
  • Gabriela Aparicio, Paula Caporal, Rosa Elena de la Torre Gómez, Chunfeng Liu, Rujipat Samransamruajkit, Nattachai Anantasit, Deborah M. Turina, Marisol Fonseca Flores, Pei Chuen Lee, Francisco J. Pilar-Orive, Hongxing Dang, Yek Kee Chor, Meixiu Ming, Juan C. Jaramillo-Bustamante, Sebastián González-Dambrauskas, Jan Hau Lee, Suyun Qian

Research output: Contribution to journalArticlepeer-review

Abstract

Evidence for the use of prophylactic anti-seizure medication (ASM) in traumatic brain injury (TBI) in reducing the occurrence of early post-traumatic seizure (EPTS) remains equivocal. This study aimed to analyze the prevalence of EPTS in children with TBI, compare clinical characteristics of those with and without EPTS, and explore the association between prophylactic ASM and EPTS. We performed an observational study among 28 pediatric intensive care units in 15 countries from January 2014 to October 2022. The rate of EPTS was compared between individuals prescribed prophylactic ASM and those who were not. Logistic regression was used to examine the association between ASM and EPTS. Among 697 children with TBI, 161 (23.1%) developed EPTS and 280 (40.2%) received prophylactic ASM treatment. Use of prophylactic ASM was associated with a lower likelihood of developing EPTS (27/280 (9.6%) vs. 134/417 (32.1%), p < 0.001). The most frequently used prophylactic ASMs were phenytoin, levetiracetam, and phenobarbital. Age ≤ 4 years and GCS ≤ 8 were associated with increased odds of developing EPTS (aOR 2.29, 95% CI 1.54–3.40, p < 0.001 and aOR 1.80, 95% CI 1.18–2.74, p = 0.01). Our data provide evidence supporting the potential protective role of prophylactic ASM against EPTS.

Original languageEnglish (US)
Article numbere70524
JournalMedComm
Volume6
Issue number12
DOIs
Publication statusPublished - Dec 2025

Fingerprint

Dive into the research topics of 'Association Between Prophylactic Anti-Seizure Medication and Early Post-Traumatic Seizures: An International Observational Multicenter Study'. Together they form a unique fingerprint.

Cite this